Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by GRAMPS1996on Jul 06, 2018 9:06pm

106 Views

Post# 28280489

Theralase Web Site BOD

Board of Directors

Guy Anderson

16+ years of financial experience, currently providing service to Aligned Capital Partners. Prior financial expertise provided to Investment Planning Counsel.

Matthew Perraton

Brings over 13 years of financial experience, most recently as a Financial Planner for TD Waterhouse and previously higher positions with BMO Nesbitt Burns and Bank of Nova Scotia.